CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDER’S EQUITY (UNAUDITED) - USD ($)		Total	Common Class B	Common Stock Common Class B		Additional Paid-in Capital	Accumulated Deficit
Share outstanding, beginning balance (in shares) at Dec. 31, 2021	[1]			12,500,000
Shareholder's equity, beginning balance at Dec. 31, 2021	[1]	$ 12,503		$ 1,250		$ 23,750	$ (12,497)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(1,751)					(1,751)
Share outstanding, ending balance (in shares) at Mar. 31, 2022	[1]			12,500,000
Shareholder's equity, ending balance at Mar. 31, 2022	[1]	10,752		$ 1,250		23,750	(14,248)
Share outstanding, beginning balance (in shares) at Dec. 31, 2021	[1]			12,500,000
Shareholder's equity, beginning balance at Dec. 31, 2021	[1]	12,503		$ 1,250		23,750	(12,497)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(2,064)
Share outstanding, ending balance (in shares) at Jun. 30, 2022	[1]			12,500,000
Shareholder's equity, ending balance at Jun. 30, 2022	[1]	10,439		$ 1,250		23,750	(14,561)
Share outstanding, beginning balance (in shares) at Mar. 31, 2022	[1]			12,500,000
Shareholder's equity, beginning balance at Mar. 31, 2022	[1]	10,752		$ 1,250		23,750	(14,248)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(313)					(313)
Share outstanding, ending balance (in shares) at Jun. 30, 2022	[1]			12,500,000
Shareholder's equity, ending balance at Jun. 30, 2022	[1]	10,439		$ 1,250		23,750	(14,561)
Share outstanding, beginning balance (in shares) at Dec. 31, 2022			12,500,000	12,500,000	[1]
Shareholder's equity, beginning balance at Dec. 31, 2022	[1]	8,961		$ 1,250		23,750	(16,039)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(300)					(300)
Share outstanding, ending balance (in shares) at Mar. 31, 2023	[1]			12,500,000
Shareholder's equity, ending balance at Mar. 31, 2023	[1]	8,661		$ 1,250		23,750	(16,339)
Share outstanding, beginning balance (in shares) at Dec. 31, 2022			12,500,000	12,500,000	[1]
Shareholder's equity, beginning balance at Dec. 31, 2022	[1]	8,961		$ 1,250		23,750	(16,039)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		3,565,636
Share outstanding, ending balance (in shares) at Jun. 30, 2023			12,500,000	12,500,000	[1]
Shareholder's equity, ending balance at Jun. 30, 2023	[1]	(19,439,305)		$ 1,250		0	(19,440,555)
Share outstanding, beginning balance (in shares) at Mar. 31, 2023	[1]			12,500,000
Shareholder's equity, beginning balance at Mar. 31, 2023	[1]	8,661		$ 1,250		23,750	(16,339)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		3,565,936					3,565,936
Sale of Private Placement Warrants		14,300,000				14,300,000
Fair value of Public Warrants at issuance		2,625,000				2,625,000
Accretion of Class A ordinary shares to redemption amount		(39,938,902)				(16,948,750)	(22,990,152)
Share outstanding, ending balance (in shares) at Jun. 30, 2023			12,500,000	12,500,000	[1]
Shareholder's equity, ending balance at Jun. 30, 2023	[1]	$ (19,439,305)		$ 1,250		$ 0	$ (19,440,555)

[1] On April 25, 2023, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. All share amounts have been retroactively restated to reflect the share surrender and share recapitalization events (see Note 4).